NLRP3 and Alzheimer disease: It demonstrated that Nlrp3 (−/−) or Casp1 (−/−) mice were largely free of spatial memory loss and other sequelae related to AD, and exhibited decreased cerebral caspase-1 and IL-1β activation, along with increased Aβ clearing (Heneka et al., 2013).